{"abstract": "Cephalon, which has already rebuffed several private merger approaches by Valeant in recent months, says the latest offer as more of the same.", "web_url": "https://dealbook.nytimes.com/2011/04/05/cephalon-rejects-valeants-5-7-billion-takeover-bid/", "snippet": "Cephalon, which has already rebuffed several private merger approaches by Valeant in recent months, says the latest offer as more of the same.", "lead_paragraph": "8:49 p.m. | Updated ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Cephalon Rejects Valeant\u2019s $5.7 Billion Takeover Bid", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Cephalon Incorporated", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": 2, "major": "N"}], "pub_date": "2011-04-05T22:48:47+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/2ef52793-34ae-5cd9-b67c-2f7b697c8c41", "word_count": 516, "uri": "nyt://article/2ef52793-34ae-5cd9-b67c-2f7b697c8c41"}